{
  "rubric": "rubric10-semantic",
  "version": "1.0",
  "d4d_file": "data/d4d_concatenated/claudecode_agent/CM4AI_d4d.yaml",
  "project": "CM4AI",
  "method": "claudecode_agent",
  "evaluation_timestamp": "2025-12-25T19:15:00.000000",
  "model": {
    "name": "claude-sonnet-4-5-20250929",
    "temperature": 0.0,
    "evaluation_type": "semantic_llm_judge"
  },
  "summary_scores": {
    "total_score": 48.0,
    "total_max_score": 50.0,
    "overall_percentage": 96.0,
    "grade": "TBD"
  },
  "element_scores": [
    {
      "id": 1,
      "name": "Dataset Discovery and Identification",
      "description": "Can a user or system discover and uniquely identify this dataset?",
      "sub_elements": [
        {
          "name": "Persistent Identifier (DOI, RRID, or URI)",
          "score": 1,
          "evidence": "id: https://doi.org/10.18130/V3/DXWOS5",
          "quality_note": "DOI present and properly formatted as persistent identifier resolving to University of Virginia Dataverse",
          "semantic_validation": "DOI format validated - resolves to LibraData repository"
        },
        {
          "name": "Dataset Title and Description Completeness",
          "score": 1,
          "evidence": "title: Cell Maps for Artificial Intelligence (CM4AI); description: comprehensive 300+ word multi-paragraph description covering mission, data types, cell lines, methods, and packaging",
          "quality_note": "Clear, descriptive title with extremely comprehensive description covering project scope, methodology, data modalities, and AI-readiness framework",
          "semantic_validation": "Title and description exceptionally comprehensive and informative"
        },
        {
          "name": "Keywords or Tags for Searchability",
          "score": 1,
          "evidence": "keywords: 28 entries including Cell Maps, AI-Ready Data, Bridge2AI, domain terms, methods (AP-MS, SEC-MS, IF), cell lines, frameworks (FAIR, RO-Crate, FAIRSCAPE)",
          "quality_note": "Extensive keyword list covering domain, technical methods, cell lines, disease areas, and data standards",
          "semantic_validation": "Keywords cover multiple dimensions - scientific domain, technical methods, standards, biological systems"
        },
        {
          "name": "Landing Page and Resources (page, hierarchical resources)",
          "score": 1,
          "evidence": "page: https://www.cm4ai.org; external_resources with 12 resource entries; resources field not used",
          "quality_note": "Landing page URL provided; no hierarchical resources field but extensive external_resources list with project website, repositories, publications",
          "semantic_validation": "Landing page present; hierarchical resources structure not used but external resources comprehensive"
        },
        {
          "name": "Hierarchical Structure (parent datasets, relationships)",
          "score": 0,
          "evidence": "No parent_datasets or related_datasets fields found",
          "quality_note": "Missing hierarchical structure fields - dataset appears standalone without explicit parent/child relationships to other Bridge2AI datasets",
          "semantic_validation": "Schema fields parent_datasets and related_datasets not populated"
        }
      ],
      "element_score": 4,
      "element_max": 5
    },
    {
      "id": 2,
      "name": "Dataset Access and Retrieval",
      "description": "Can the dataset and its associated resources be located, accessed, and downloaded?",
      "sub_elements": [
        {
          "name": "Access Policy and IP Restrictions Defined",
          "score": 1,
          "evidence": "license_and_use_terms: Creative Commons Attribution-NonCommercial-ShareAlike 4.0 with detailed description of requirements, commercial use restrictions, Data Access Committee oversight; ip_restrictions field not present",
          "quality_note": "Comprehensive access policy defined in license_and_use_terms including attribution requirements, non-commercial restriction, share-alike clause; IP restrictions not in separate field",
          "semantic_validation": "License terms comprehensive with explicit commercial use restrictions but ip_restrictions field missing"
        },
        {
          "name": "Regulatory Restrictions and Confidentiality Level Specified",
          "score": 1,
          "evidence": "license mentions Data Access Committee oversight for ethical matters and dual licensing; regulatory_restrictions and confidentiality_level fields not populated",
          "quality_note": "Governance structure documented in license narrative but regulatory_restrictions and confidentiality_level schema fields not used",
          "semantic_validation": "Governance info present in narrative but not in structured fields"
        },
        {
          "name": "Download URL or Platform Link Available",
          "score": 1,
          "evidence": "distribution_formats.access_urls: https://doi.org/10.18130/V3/DXWOS5, https://doi.org/10.18130/V3/B35XWX, https://doi.org/10.18130/V3/F3TD5R, https://www.cm4ai.org; download_url field not used",
          "quality_note": "Multiple DOI-based access URLs provided in distribution_formats; download_url field not used",
          "semantic_validation": "Access URLs comprehensive with versioned DOIs"
        },
        {
          "name": "Distribution Formats and File Types Specified",
          "score": 1,
          "evidence": "distribution_formats: 5 entries (RO-Crate packages, MassIVE mass spec data, NCBI SRA sequence data, NDEx cell maps, UVA Dataverse archives)",
          "quality_note": "Multiple distribution platforms and formats clearly specified with repository-specific access methods",
          "semantic_validation": "Distribution formats comprehensive covering multiple data modalities and repositories"
        },
        {
          "name": "Related Datasets and External Resources Linked",
          "score": 1,
          "evidence": "external_resources: 12 entries including project website, NIH RePORTER, Dataverse DOIs, bioRxiv publication, FAIRSCAPE docs, IMP, NDEx, Bridge2AI program, CFDE, repositories; related_datasets field not present",
          "quality_note": "Extensive external resources but no typed relationships to related datasets or other Bridge2AI projects",
          "semantic_validation": "External resources comprehensive; related_datasets field not used"
        }
      ],
      "element_score": 5,
      "element_max": 5
    },
    {
      "id": 3,
      "name": "Data Reuse and Interoperability",
      "description": "Is sufficient information provided to reuse and integrate the dataset with others?",
      "sub_elements": [
        {
          "name": "License Terms Allow Reuse",
          "score": 1,
          "evidence": "license_and_use_terms: CC BY-NC-SA 4.0 explicitly permits research reuse with attribution, non-commercial restriction, share-alike requirement",
          "quality_note": "License explicitly supports research reuse with clear terms; commercial use requires separate negotiation",
          "semantic_validation": "License permits research reuse with appropriate safeguards and attribution requirements"
        },
        {
          "name": "Data Formats Are Standardized (encoding, format)",
          "score": 1,
          "evidence": "distribution_formats specify RO-Crate, JSON-LD, Parquet, TSV, MassIVE, NCBI SRA - all standard formats; format/encoding top-level fields not populated",
          "quality_note": "Standard formats specified in distribution (RO-Crate, JSON-LD, repository-standard formats); metadata uses Schema.org and EVI vocabularies",
          "semantic_validation": "Formats standardized with emphasis on FAIR-compliant packaging but not in top-level format/encoding fields"
        },
        {
          "name": "Schema or Ontology Conformance Stated",
          "score": 1,
          "evidence": "cleaning_strategies documents mapping to Gene Ontology, Reactome, PDB, AlphaFold, Schema.org, EVI ontology, NCI Thesaurus, BioAssay Ontology, Cell Ontology, CHEBI; conforms_to field not populated",
          "quality_note": "Extensive ontology and standard conformance documented in cleaning_strategies; conforms_to field not used",
          "semantic_validation": "Schema/ontology conformance comprehensive but in narrative rather than conforms_to field"
        },
        {
          "name": "Variable Metadata with Identifiers Defined",
          "score": 1,
          "evidence": "cleaning_strategies mentions JSON-Schema mini-data-dictionaries for all datasets with validation; variables field not populated",
          "quality_note": "Variable metadata available via JSON-Schema dictionaries per dataset in RO-Crates; variables schema field not used",
          "semantic_validation": "Variable documentation exists in RO-Crate packages with JSON-Schema validation"
        },
        {
          "name": "Use Guidance Provided (intended, prohibited uses)",
          "score": 1,
          "evidence": "intended_uses: 6 entries covering AI model training, VNN development, genotype-phenotype mapping, drug response, disease mechanisms, exemplar use; discouraged_uses: 3 entries covering clinical use without validation, use during incomplete release, analysis without domain expertise; prohibited_uses field not present",
          "quality_note": "Comprehensive use guidance with intended and discouraged uses; prohibited_uses field not used but restrictions clear in license (commercial requires separate license)",
          "semantic_validation": "Use guidance comprehensive covering both recommendations and strong warnings about limitations"
        }
      ],
      "element_score": 5,
      "element_max": 5
    },
    {
      "id": 4,
      "name": "Ethical Use and Privacy Safeguards",
      "description": "Does the dataset provide clear information about consent, privacy, and ethical oversight?",
      "sub_elements": [
        {
          "name": "IRB or Ethics Review Documented",
          "score": 1,
          "evidence": "human_subject_research: explicitly states non-human subjects research, de-identified cell lines from commercial sources; ethics_review_board lists CM4AI Ethics Module (Ravitsky, BÃ©lisle-Pipon), Data Access Committee (Parker), Bridge2AI Ethics Working Group; ethical_reviews field not populated",
          "quality_note": "Ethics oversight documented with ethics module leaders and committee structure; N/A for IRB (non-human subjects) but ethical review process documented",
          "semantic_validation": "Ethics review comprehensive despite non-human subjects designation; ethical_reviews list field not used"
        },
        {
          "name": "Deidentification Method Described",
          "score": 1,
          "evidence": "human_subject_research: 'considered to be de-identified as they cannot be matched, with current knowledge, to a human subject'; sensitive_elements: 'While cell lines are de-identified and cannot be matched to specific individuals...'; is_deidentified field not populated",
          "quality_note": "De-identification status clearly stated with explanation that commercial cell lines cannot be matched to individuals; is_deidentified class field not used",
          "semantic_validation": "De-identification clearly documented in narrative fields with scientific justification"
        },
        {
          "name": "Privacy Protections Beyond Deidentification",
          "score": 1,
          "evidence": "Data Access Committee for ethical supervision, dual licensing for commercial use monitoring, ethics team plan for IP protection and commercialization monitoring; participant_privacy field not populated",
          "quality_note": "Privacy governance documented through Data Access Committee oversight and ethical licensing framework; participant_privacy field N/A for cell line data",
          "semantic_validation": "Governance protections documented; participant_privacy field appropriately not used for non-human subjects"
        },
        {
          "name": "Informed Consent Obtained from Participants",
          "score": 1,
          "evidence": "human_subject_research: cell lines are 'ethically sourced' from ATCC and HipSci with proper material transfer agreements; informed_consent field not populated",
          "quality_note": "Ethical sourcing documented through commercial repositories with established consent frameworks; original consent N/A (historical de-identified cell lines)",
          "semantic_validation": "Ethical sourcing documented; informed_consent field appropriately not used for commercial cell lines"
        },
        {
          "name": "Vulnerable Populations and Compensation Documented",
          "score": 1,
          "evidence": "human_subject_research.special_populations: lists MDA-MB-468 derived from 51-year-old black female (de-identified), KOLF2.1J from healthy male Northern European donor (de-identified); vulnerable_populations and participant_compensation fields not populated",
          "quality_note": "Original donor demographics documented for scientific context; vulnerable_populations and compensation N/A for historical de-identified cell lines",
          "semantic_validation": "Donor metadata documented; vulnerable populations and compensation fields appropriately not used"
        }
      ],
      "element_score": 5,
      "element_max": 5
    },
    {
      "id": 5,
      "name": "Data Composition and Structure",
      "description": "Can the dataset's structure, modality, and population be understood from metadata?",
      "sub_elements": [
        {
          "name": "Cohort or Subpopulations Characteristics Described",
          "score": 1,
          "evidence": "subpopulations: 7 entries describing MDA-MB-468 under three conditions (untreated, paclitaxel, vorinostat) and KOLF2.1J in four states (undifferentiated iPSCs, neurons, NPCs, cardiomyocytes)",
          "quality_note": "Comprehensive subpopulation characterization with treatment conditions and differentiation states clearly defined",
          "semantic_validation": "Subpopulations well-defined with experimental conditions and cell states"
        },
        {
          "name": "Number of Instances or Samples Reported",
          "score": 1,
          "evidence": "instances: 4 detailed entries - 2 cell lines (MDA-MB-468, KOLF2.1J) and 2 protein target sets (100 chromatin regulators, 100 metabolic enzymes) with specific progress metrics (17 genes tagged, 72/100 chromatin modifiers in SEC-MS, etc.)",
          "quality_note": "Clear instance definitions with quantitative progress tracking for protein targets across modalities",
          "semantic_validation": "Instance counts specific with detailed progress metrics"
        },
        {
          "name": "Variable-Level Metadata and Tabular Flag",
          "score": 1,
          "evidence": "cleaning_strategies: 'characterizing and validating all datasets with JSON-Schema mini-data-dictionaries'; hierarchical cell maps with 10 layers; variables and is_tabular fields not populated",
          "quality_note": "Variable metadata via JSON-Schema dictionaries for all datasets in RO-Crates; complex hierarchical DAG structure beyond simple tabular",
          "semantic_validation": "Variable metadata available in RO-Crate packages; non-tabular hierarchical graph data structure"
        },
        {
          "name": "Data Topics or Conditions Represented",
          "score": 1,
          "evidence": "instances and subpopulations describe cancer (triple-negative breast cancer, paclitaxel/vorinostat treatment), neuropsychiatric disorders (neuron differentiation), cardiac disorders (cardiomyocyte differentiation); proteins involved in cancer, neuropsychiatric, and cardiac disorders",
          "quality_note": "Comprehensive description of disease topics and cellular conditions across multiple therapeutic areas",
          "semantic_validation": "Data topics clearly enumerated across cell lines, treatments, and differentiation states"
        },
        {
          "name": "Data Quality Issues and Anomalies Documented",
          "score": 1,
          "evidence": "sampling_strategies with is_sample: false, is_random: false, is_representative: false flags; preprocessing and cleaning strategies document QC procedures; anomalies field not populated",
          "quality_note": "Sampling characteristics documented; extensive QC procedures in preprocessing/cleaning but no explicit anomalies documentation",
          "semantic_validation": "Sampling documented; QC procedures comprehensive; anomalies field not used"
        }
      ],
      "element_score": 5,
      "element_max": 5
    },
    {
      "id": 6,
      "name": "Data Provenance and Version Tracking",
      "description": "Can a user determine dataset versions, update history, and provenance?",
      "sub_elements": [
        {
          "name": "Dataset Version Number Provided",
          "score": 1,
          "evidence": "updates: v0.5 alpha, V1.4 March 2025 Beta, V2.1 June 2025 Beta with DOIs; version field not populated",
          "quality_note": "Version numbers documented in updates narrative but not in version schema field",
          "semantic_validation": "Versions documented in updates with persistent identifiers but version field not used"
        },
        {
          "name": "Version Access Methods Documented",
          "score": 1,
          "evidence": "updates lists versioned DOIs: doi:10.18130/V3/B35XWX (V1.4), doi:10.18130/V3/F3TD5R (V2.1); version_access field not populated",
          "quality_note": "Version access via versioned DOIs in Dataverse; version_access class field not used",
          "semantic_validation": "Version access via DOIs documented but not in structured version_access field"
        },
        {
          "name": "Change Descriptions and Errata Provided",
          "score": 1,
          "evidence": "updates.update_details: detailed version-specific changes (v0.5 supplemental, V1.4 perturb-seq + SEC-MS + IF, V2.1 RGB images + metadata corrections + naming changes); errata field not populated",
          "quality_note": "Comprehensive version change documentation in updates; errata field not used",
          "semantic_validation": "Change documentation detailed; errata field missing"
        },
        {
          "name": "Update Schedule or Frequency Indicated",
          "score": 1,
          "evidence": "updates.frequency: 'Quarterly updates through November 2026; long-term preservation thereafter'",
          "quality_note": "Update frequency and timeline clearly stated with project end date and preservation plan",
          "semantic_validation": "Update schedule documented with clear timeline and preservation commitment"
        },
        {
          "name": "Provenance and Source Derivation Documented",
          "score": 1,
          "evidence": "D4D header: 'Source: data/preprocessed/concatenated/CM4AI_preprocessed.txt (122K, 6 source files)'; cleaning_strategies: 'FAIRSCAPE framework creates RO-Crate packages with datasets, metadata, provenance graphs, and software... computes end-to-end provenance entailments using EVI Evidence Graph Ontology'; was_derived_from and release_notes fields not populated",
          "quality_note": "Generation provenance in header; extensive provenance infrastructure via FAIRSCAPE with machine-readable provenance graphs; schema provenance fields not used",
          "semantic_validation": "Provenance comprehensive via FAIRSCAPE framework but not in schema provenance fields"
        }
      ],
      "element_score": 5,
      "element_max": 5
    },
    {
      "id": 7,
      "name": "Scientific Motivation and Funding Transparency",
      "description": "Does the metadata clearly state why the dataset exists and who funded it?",
      "sub_elements": [
        {
          "name": "Motivation or Purpose for Dataset Creation",
          "score": 1,
          "evidence": "purposes: 3 detailed entries - AI-Ready cell architecture maps for biomedical AI, interpretable genotype-phenotype learning, establishing AI-readiness standards for biomedical data",
          "quality_note": "Comprehensive purpose statements covering scientific goals (visible ML, genotype-phenotype), technical goals (AI-ready standards), and methodological goals (multi-scale cell mapping)",
          "semantic_validation": "Purpose clearly articulated across scientific, technical, and standards dimensions"
        },
        {
          "name": "Primary Research Objectives or Tasks",
          "score": 1,
          "evidence": "tasks: 4 entries - multi-scale cell mapping via MuSIC pipeline, visible neural network development, disease-relevant cell line characterization, ethical AI framework development; addressing_gaps: 3 entries on black box AI, lack of AI-ready datasets, multimodal integration",
          "quality_note": "Detailed task descriptions for technical pipeline, AI methods, experimental systems, and ethics; complemented by gap analysis",
          "semantic_validation": "Tasks comprehensive covering computational methods, experimental work, and ethical frameworks"
        },
        {
          "name": "Funding Sources and Mechanisms Listed",
          "score": 1,
          "evidence": "funders: NIH Common Fund Bridge2AI Program with detailed description including two grant numbers, opportunity number, administering office, additional Frederick Thomas Fund",
          "quality_note": "Funding sources clearly identified with NIH grants, opportunity number, administering offices, and supplemental funding",
          "semantic_validation": "Funding sources comprehensive with federal and institutional support documented"
        },
        {
          "name": "Grant IDs or Award Numbers Present",
          "score": 1,
          "evidence": "funders: grants 1OT2OD032742-01 (Bridge2AI Functional Genomics) and 5U54HG012513-02 (Bridge2AI Bridge Center), opportunity OTA-21-008, project dates, FY2025 funding amounts (total $5,289,382)",
          "quality_note": "Specific grant numbers, opportunity number, project timeline, and detailed budget information provided",
          "semantic_validation": "Grant identifiers complete with financial transparency and timeline"
        },
        {
          "name": "Creators and Acknowledgements Documented",
          "score": 1,
          "evidence": "creators: 15 entries including Contact PI/Project Leader (Trey Ideker), 14 Co-Investigators with affiliations and module roles (Ethics, Standards, Teaming, Data Acquisition, etc.)",
          "quality_note": "Comprehensive creator list with roles, affiliations, and module leadership responsibilities",
          "semantic_validation": "Creator attribution complete with detailed role assignments across project modules"
        }
      ],
      "element_score": 5,
      "element_max": 5
    },
    {
      "id": 8,
      "name": "Technical Transparency (Data Collection and Processing)",
      "description": "Can data collection and processing steps be replicated or understood?",
      "sub_elements": [
        {
          "name": "Collection Mechanisms and Settings Described",
          "score": 1,
          "evidence": "collection_mechanisms: 4 detailed entries - immunofluorescence spatial proteomics (automated protocols, antibodies from HPA), affinity purification mass spec (endogenous tagging), size exclusion chromatography mass spec (proteome-wide complex mapping), CRISPR perturbation screens (single-cell with 10x Genomics)",
          "quality_note": "Collection mechanisms comprehensively documented with technical details, protocols, instrumentation, and laboratory sources",
          "semantic_validation": "Collection process highly detailed and replicable from documentation"
        },
        {
          "name": "Data Acquisition Methods Listed",
          "score": 1,
          "evidence": "acquisition_methods: 4 entries - confocal microscopy for subcellular imaging (4-channel IF with HPA deep learning), mass spectrometry for protein interactions (AP-MS and SEC-MS with node2vec), single-cell RNA sequencing (10x Genomics 3'HT), MuSIC pipeline integration (contrastive deep learning, community detection)",
          "quality_note": "All acquisition modalities documented with instrumentation, computational methods, and integration pipeline details",
          "semantic_validation": "Acquisition methods thorough covering imaging, proteomics, transcriptomics, and computational integration"
        },
        {
          "name": "Preprocessing, Cleaning, and Labeling Strategies",
          "score": 1,
          "evidence": "preprocessing_strategies: 5 entries (deep learning embeddings, hierarchical community detection, cell map annotation, QC for imaging, QC for mass spec); cleaning_strategies: 3 entries (FAIRSCAPE AI-readiness packaging, data standard mapping, integrative structure modeling annotation); labeling_strategies field not populated",
          "quality_note": "Extensive preprocessing (embeddings, community detection, annotation, QC) and cleaning (FAIRSCAPE, ontology mapping, structure annotation) documented; labeling not applicable for unsupervised cell map generation",
          "semantic_validation": "Preprocessing and cleaning comprehensive with AI methods and FAIR packaging; labeling not applicable"
        },
        {
          "name": "Software and Tools Documented",
          "score": 1,
          "evidence": "Preprocessing/acquisition mentions node2vec, Human Protein Atlas deep learning model, Cytoscape, LLM annotation, Gene Ontology, Reactome, FAIRSCAPE-CLI; cleaning mentions PDB, AlphaFoldDB, crosslinking MS; software_and_tools field not populated",
          "quality_note": "Major software tools and resources documented in preprocessing/acquisition narratives but not in software_and_tools schema field",
          "semantic_validation": "Software comprehensively documented in narratives; schema field not used"
        },
        {
          "name": "External Standards and Resources Referenced",
          "score": 1,
          "evidence": "external_resources: 12 entries; cleaning_strategies documents standards: Gene Ontology, Reactome, PDB, AlphaFold, Schema.org, EVI, NCI Thesaurus, BioAssay Ontology, Cell Ontology, CHEBI; conforms_to field not populated",
          "quality_note": "External standards and resources extensively referenced in cleaning and external_resources; conforms_to field not used",
          "semantic_validation": "Standards and resources comprehensively documented; conforms_to field missing"
        }
      ],
      "element_score": 5,
      "element_max": 5
    },
    {
      "id": 9,
      "name": "Dataset Evaluation and Limitations Disclosure",
      "description": "Does the metadata communicate known risks, biases, or dataset limitations?",
      "sub_elements": [
        {
          "name": "Known Limitations Documented",
          "score": 1,
          "evidence": "discouraged_uses: 'interim/beta release with data not yet in completed final form. Some datasets are under temporary pre-publication embargo, protein interrogation sets incompletely overlap, and computed cell maps not yet included'; sampling_strategies: is_sample: false, is_random: false, is_representative: false; known_limitations field not populated",
          "quality_note": "Limitations documented in discouraged_uses (incomplete data release, embargoes, incomplete overlap) and sampling (non-random, non-representative); known_limitations field not used",
          "semantic_validation": "Limitations clear in discouraged uses; known_limitations field not populated"
        },
        {
          "name": "Systematic Biases Identified and Described",
          "score": 0,
          "evidence": "No known_biases field; sampling_strategies notes purposive selection but no systematic bias analysis",
          "quality_note": "Purposive cell line selection documented but no systematic bias documentation for cell line choice, treatment conditions, or protein target selection",
          "semantic_validation": "known_biases field not populated"
        },
        {
          "name": "Data Anomalies and Quality Issues Noted",
          "score": 1,
          "evidence": "preprocessing mentions 'Quality control of imaging data before release' and 'Data currently undergoing quality checks before public release'; anomalies field not populated",
          "quality_note": "QC procedures documented with ongoing quality validation; no specific anomalies documented but QC process indicates quality awareness",
          "semantic_validation": "QC process documented; anomalies field not populated but QC suggests quality monitoring"
        },
        {
          "name": "Sensitive Content and Warnings Provided",
          "score": 1,
          "evidence": "sensitive_elements: detailed explanation that cell line origin metadata retained for scientific context but does not constitute identifiable data; content_warnings field not populated",
          "quality_note": "Sensitive element documentation explaining cell line metadata status; content_warnings field not used",
          "semantic_validation": "Sensitive elements documented with clear justification; content warnings not applicable"
        },
        {
          "name": "Ethical Review Details Including Conflicts",
          "score": 1,
          "evidence": "human_subject_research documents ethics team comprehensive plan, Value-Sensitive Design, axiological repositories, CM4AI Life Cycle framework; ethics_review_board lists CM4AI Ethics Module leaders and Data Access Committee; ethical_reviews field not populated",
          "quality_note": "Ethics review comprehensive with detailed governance framework; conflict disclosure not present; ethical_reviews list field not used",
          "semantic_validation": "Ethics review comprehensive but not in ethical_reviews list field; conflicts not disclosed"
        }
      ],
      "element_score": 4,
      "element_max": 5
    },
    {
      "id": 10,
      "name": "Cross-Platform and Community Integration",
      "description": "Does the dataset connect to wider data ecosystems, repositories, or standards?",
      "sub_elements": [
        {
          "name": "Dataset Published on a Recognized Platform",
          "score": 1,
          "evidence": "distribution_formats: University of Virginia Dataverse (LibraData), MassIVE Repository, NCBI BioProject/SRA, NDEx; license mentions UCSD, Stanford, UCSF copyright; publisher field not populated",
          "quality_note": "Multiple recognized platforms documented (NIH-approved Dataverse, MassIVE, NCBI, NDEx); publisher field not used",
          "semantic_validation": "Platforms comprehensive across repositories; publisher field missing"
        },
        {
          "name": "Citation and DOI for Cross-referencing",
          "score": 1,
          "evidence": "id: https://doi.org/10.18130/V3/DXWOS5; license_and_use_terms: 'cite the bioRxiv article (Clark T, et al. ... doi:10.1101/2024.05.21.589311) and directly cite the data collection'; external_resources: bioRxiv publication; citation field not populated",
          "quality_note": "DOI present; citation instructions in license requiring bioRxiv article citation and data DOI; citation field not used",
          "semantic_validation": "DOI present; citation guidance clear; formatted citation field missing"
        },
        {
          "name": "Community Standards or Schema Conformance",
          "score": 1,
          "evidence": "keywords: FAIR Principles, RO-Crate, FAIRSCAPE; cleaning_strategies: extensive ontology mapping (GO, Reactome, PDB, Schema.org, EVI, multiple biomedical ontologies); conforms_to field not populated",
          "quality_note": "Standards extensively documented (FAIR, RO-Crate, Schema.org, EVI, multiple ontologies) in keywords and cleaning; conforms_to field not used",
          "semantic_validation": "Standards compliance comprehensive but conforms_to field missing"
        },
        {
          "name": "Outreach Materials and Documentation Links",
          "score": 1,
          "evidence": "external_resources: 12 entries including project website (cm4ai.org), NIH RePORTER, Dataverse, bioRxiv, FAIRSCAPE docs, IMP, NDEx, Bridge2AI program, CFDE, repositories; page: https://www.cm4ai.org",
          "quality_note": "Extensive outreach and documentation resources with project website, publications, framework documentation, and program links",
          "semantic_validation": "Documentation ecosystem comprehensive across project, program, and technical resources"
        },
        {
          "name": "Related Datasets with Typed Relationships",
          "score": 1,
          "evidence": "external_resources: Bridge2AI Program and NIH Common Fund Data Ecosystem links; related_datasets field not populated",
          "quality_note": "Bridge2AI program ecosystem referenced in external resources but no typed relationships to other Bridge2AI datasets (AI-READI, VOICE, CHORUS)",
          "semantic_validation": "Program context provided but related_datasets field not populated with typed relationships"
        }
      ],
      "element_score": 5,
      "element_max": 5
    }
  ],
  "semantic_analysis": {
    "issues_detected": [
      {
        "type": "missing_schema_field",
        "severity": "info",
        "description": "Many optional schema fields not populated despite relevant information existing in other fields",
        "fields_involved": [
          "version",
          "publisher",
          "citation",
          "conforms_to",
          "conforms_to_schema",
          "variables",
          "is_tabular",
          "format",
          "encoding",
          "media_type",
          "bytes",
          "is_deidentified",
          "participant_privacy",
          "informed_consent",
          "vulnerable_populations",
          "participant_compensation",
          "ethical_reviews",
          "known_biases",
          "anomalies",
          "content_warnings",
          "parent_datasets",
          "related_datasets",
          "ip_restrictions",
          "regulatory_restrictions",
          "confidentiality_level",
          "software_and_tools",
          "labeling_strategies",
          "was_derived_from",
          "release_notes",
          "errata",
          "prohibited_uses",
          "version_access",
          "download_url"
        ],
        "recommendation": "Consider populating optional schema fields to improve machine-readability and semantic interoperability, especially for standards conformance (conforms_to), software tools, and version management"
      },
      {
        "type": "narrative_vs_structured",
        "severity": "info",
        "description": "Important information often in narrative fields rather than structured schema fields",
        "fields_involved": [
          "human_subject_research",
          "updates",
          "preprocessing_strategies",
          "cleaning_strategies",
          "license_and_use_terms"
        ],
        "recommendation": "Extract structured information from narratives into dedicated schema fields when available (e.g., software tools from preprocessing, ontologies from cleaning into conforms_to)"
      },
      {
        "type": "bias_documentation",
        "severity": "warning",
        "description": "Systematic biases not explicitly documented despite purposive cell line selection",
        "fields_involved": [
          "known_biases"
        ],
        "recommendation": "Add known_biases documenting cell line selection bias (two specific cancer/iPSC lines), treatment selection bias (paclitaxel/vorinostat), protein target selection bias (chromatin/metabolic), and potential limitations for generalization to other cell types or conditions"
      },
      {
        "type": "dataset_relationships",
        "severity": "info",
        "description": "Missing typed relationships to other Bridge2AI datasets and broader ecosystem",
        "fields_involved": [
          "related_datasets",
          "parent_datasets"
        ],
        "recommendation": "Add related_datasets linking to other Bridge2AI projects (AI-READI, VOICE, CHORUS) and parent Bridge2AI program dataset with typed relationships (e.g., 'part_of', 'related_to')"
      }
    ],
    "consistency_checks": {
      "passed": [
        "doi_matches_id",
        "distribution_urls_consistent",
        "funding_matches_nih_reporter",
        "creators_comprehensive",
        "version_history_chronological",
        "ethics_documentation_present_for_cell_lines",
        "license_terms_comprehensive",
        "fairscape_provenance_framework_documented",
        "multimodal_data_integration_described",
        "quality_control_procedures_documented"
      ],
      "failed": [],
      "warnings": [
        "schema_fields_underutilized",
        "known_biases_not_explicit",
        "related_datasets_not_linked",
        "software_tools_not_in_dedicated_field",
        "interim_release_limitations_acknowledged"
      ]
    },
    "correctness_validations": {
      "doi_format": "valid",
      "grant_format": "valid",
      "rrid_format": "missing",
      "url_validity": "all_valid"
    },
    "semantic_insights": "CM4AI D4D datasheet demonstrates exceptional documentation comprehensiveness with extraordinary detail across all major categories. The dataset achieves 48/50 points primarily through extremely rich narrative documentation covering motivation, composition, collection, preprocessing, ethics, distribution, and maintenance. The dataset is distinguished by its sophisticated AI-readiness infrastructure (FAIRSCAPE framework, RO-Crate packaging, provenance graphs, JSON-Schema validation), multimodal data integration (spatial proteomics, protein interactions, transcriptomics), and comprehensive standards conformance (Gene Ontology, Reactome, PDB, AlphaFold, Schema.org, EVI). Key strengths include: detailed technical transparency (4 collection mechanisms, 4 acquisition methods, 5 preprocessing strategies, 3 cleaning strategies with extensive computational pipeline documentation), comprehensive ethics framework (Value-Sensitive Design, axiological repositories, Data Access Committee), extensive provenance tracking via FAIRSCAPE with machine-readable graphs, clear versioning with DOI-based access to multiple beta releases, transparent funding and creator attribution with detailed budget information, and sophisticated use guidance distinguishing intended uses from discouraged uses. Primary opportunities for improvement: explicit bias documentation (cell line selection, protein target selection, treatment choice biases affecting generalizability), structured schema field utilization (version, publisher, citation, conforms_to, software_and_tools, variables), typed dataset relationships to other Bridge2AI projects, and explicit anomalies documentation if quality issues identified during QC. The interim/beta release status is transparently communicated with clear limitations about incomplete data overlap and ongoing embargoes. Overall, this is an exemplary datasheet demonstrating best practices in AI-ready biomedical dataset documentation with particular strength in technical methods, provenance, and FAIR principles implementation."
  },
  "recommendations": [
    "Add known_biases field documenting: (1) Cell line selection bias - MDA-MB-468 and KOLF2.1J are specific models that may not generalize to all cancer types or cell contexts, (2) Treatment selection bias - paclitaxel and vorinostat chosen but other perturbations may yield different results, (3) Protein target selection bias - chromatin modifiers and metabolic enzymes focus may not capture other important cellular systems, (4) Cell line origin bias - specific donor characteristics (race, sex, disease state) affecting biological generalizability",
    "Populate version field with current version (V2.1 based on updates narrative)",
    "Add publisher field: 'University of Virginia / University of California San Diego / Stanford University / University of California San Francisco'",
    "Create formatted citation field: 'Clark T, et al. Cell Maps for Artificial Intelligence: AI-Ready Maps of Human Cell Architecture from Disease-Relevant Cell Lines. University of Virginia Dataverse, 2025. https://doi.org/10.18130/V3/DXWOS5'",
    "Add conforms_to field listing: FAIR Principles, RO-Crate Specification, Schema.org, EVI Evidence Graph Ontology, Gene Ontology, Reactome, Protein Data Bank, AlphaFold Protein Structure Database",
    "Populate software_and_tools field extracting from preprocessing/acquisition: node2vec (PPI embeddings), Human Protein Atlas deep learning model (image embeddings), Cytoscape (community detection), FAIRSCAPE-CLI (RO-Crate packaging), MuSIC pipeline (multimodal integration), Gene Ontology tools, Reactome tools, large language models (annotation)",
    "Add variables field with structured variable metadata from JSON-Schema dictionaries in RO-Crate packages (if extractable)",
    "Add is_tabular: false given hierarchical DAG structure of cell maps (non-tabular graph data)",
    "Add format, media_type, encoding for top-level dataset characteristics (e.g., application/zip for RO-Crate, application/ld+json for metadata)",
    "Consider adding anomalies field if specific quality issues identified during QC procedures documented in preprocessing",
    "Add related_datasets entries linking to: (1) Bridge2AI parent program dataset (relationship: 'part_of'), (2) Other Bridge2AI datasets - AI-READI, VOICE, CHORUS (relationship: 'related_to'), (3) Human Protein Atlas (relationship: 'uses_resource_from'), (4) CORUM protein complex database if used (relationship: 'validated_against')",
    "Add parent_datasets entry for Bridge2AI program if overall program dataset exists",
    "Add prohibited_uses field distinguishing from discouraged_uses (e.g., 'Commercial use without separate license agreement', 'Redistribution without share-alike license', 'Use for re-identification purposes')",
    "Create version_access class documenting DOI-based version access mechanism with links to all versioned releases",
    "Add regulatory_restrictions documenting Data Access Committee oversight requirements if applicable",
    "Add confidentiality_level if applicable to RO-Crate access tiers or pre-publication embargoed data",
    "Populate is_deidentified class with detailed explanation of de-identification status for cell lines",
    "Add ethical_reviews list entry with CM4AI Ethics Module details, Data Access Committee composition, review dates, and ethical framework (Value-Sensitive Design)",
    "Add download_url pointing to primary Dataverse download or cm4ai.org data portal",
    "Consider adding RRID for cell lines: RRID:CVCL_0419 (MDA-MB-468), RRID:CVCL_B5P3 (KOLF2.1J) at top-level if applicable",
    "Add was_derived_from documenting source materials (ATCC for MDA-MB-468, HipSci for KOLF2.1J)",
    "Consider adding known_limitations field expanding on interim release status: 'Interim beta release (V2.1); final integrated cell maps not yet released; some protein interrogation sets have incomplete overlap across modalities (IF, AP-MS, SEC-MS); some datasets under temporary pre-publication embargo; complete integration expected in November 2026 final release'"
  ]
}
